Home » Topics » BioWorld Science

BioWorld Science
RSS

Chengdu Baiyu Pharmaceutical describes G12C mutant GTPase KRAS inhibitors

June 20, 2022

New MRGPRX2 antagonists identified at Bioardis

June 20, 2022

Novel humanized mouse model of posterior fossa A ependymoma

June 20, 2022

Magmas inhibition as new therapeutic strategy in medulloblastoma

June 20, 2022

CD47 blockade with 225Ac-anti-CD33 radioimmunoconjugate in acute myeloid leukemia

June 20, 2022

Alpha-emitting radioimmunotherapy: using throrium-227 and antibody conjugates

June 20, 2022

Cytokine promotes heart repair after infarct

June 20, 2022

PIK3C2B variants impact mTOR pathway and lead to lipid signaling-driven focal epilepsy

June 20, 2022

Combinatorial analytics identifies hundreds of precise drug repositioning opportunities

June 17, 2022

TULP3 mutations cause degeneration of major organs

June 17, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026